Overview
Alström Syndrome and Bardet-Biedl Syndrome (BBS) are the two ciliopathies most often confused. Both cause progressive retinal degeneration, childhood obesity, and metabolic problems. But they're caused by different genes, follow different timelines, and call for different surveillance and care. Here's a side-by-side comparison families and clinicians can use.
At a glance
Feature
Causative genes
Alström Syndrome
One gene: ALMS1
Bardet-Biedl Syndrome
More than 22 genes (BBS1–BBS22)
Feature
Inheritance
Alström Syndrome
Autosomal recessive
Bardet-Biedl Syndrome
Autosomal recessive (with rare modifier effects)
Feature
Estimated prevalence
Alström Syndrome
~1 in 1,000,000
Bardet-Biedl Syndrome
~1 in 100,000–160,000
Feature
Polydactyly (extra fingers/toes)
Alström Syndrome
Absent
Bardet-Biedl Syndrome
Common (60–80% of cases)
Feature
Intellectual ability
Alström Syndrome
Typical range in most
Bardet-Biedl Syndrome
Mild to moderate intellectual disability common
Feature
Cardiomyopathy
Alström Syndrome
Common in infancy and adulthood
Bardet-Biedl Syndrome
Rare
Feature
Hearing loss
Alström Syndrome
Sensorineural, progressive, ~70% in first decade
Bardet-Biedl Syndrome
Less common and milder
Feature
Insulin resistance / T2DM
Alström Syndrome
Severe and near-universal
Bardet-Biedl Syndrome
Common but typically less severe
Feature
Renal disease
Alström Syndrome
Slowly progressive nephropathy
Bardet-Biedl Syndrome
Structural kidney malformations more common
Feature
Genitourinary anomalies
Alström Syndrome
Detrusor dyssynergia later in life
Bardet-Biedl Syndrome
Hypogonadism and structural anomalies
| Feature | Alström Syndrome | Bardet-Biedl Syndrome |
|---|---|---|
| Causative genes | One gene: ALMS1 | More than 22 genes (BBS1–BBS22) |
| Inheritance | Autosomal recessive | Autosomal recessive (with rare modifier effects) |
| Estimated prevalence | ~1 in 1,000,000 | ~1 in 100,000–160,000 |
| Polydactyly (extra fingers/toes) | Absent | Common (60–80% of cases) |
| Intellectual ability | Typical range in most | Mild to moderate intellectual disability common |
| Cardiomyopathy | Common in infancy and adulthood | Rare |
| Hearing loss | Sensorineural, progressive, ~70% in first decade | Less common and milder |
| Insulin resistance / T2DM | Severe and near-universal | Common but typically less severe |
| Renal disease | Slowly progressive nephropathy | Structural kidney malformations more common |
| Genitourinary anomalies | Detrusor dyssynergia later in life | Hypogonadism and structural anomalies |
Why they're so often confused
Both Alström and BBS belong to a family of conditions called ciliopathies — disorders caused by problems with primary cilia, the antenna-like structures on cells.¹ Cilia are everywhere, so when they fail, multiple body systems are affected. The shared "ciliopathy phenotype" includes retinal degeneration, obesity, and renal involvement.
This shared pattern makes the early presentation similar, and a child with one condition can be misdiagnosed as having the other for years.²
Where they diverge
Polydactyly
The single most useful distinguishing feature on physical exam is polydactyly — extra fingers or toes. About 60–80% of children with BBS are born with polydactyly. It's surgically removed in many cases, so older children may not have visible extra digits, but the surgical history is on record. Polydactyly is not a feature of Alström.
Cognitive function
Most people with BBS have some degree of intellectual disability, ranging from mild to moderate. Most people with Alström have intelligence in the typical range. Up to 30% of children with Alström have a learning disability, but this is largely related to vision and hearing loss rather than primary cognitive impairment.³
Cardiomyopathy
Cardiomyopathy is a hallmark of Alström and is rare in BBS. More than 60% of children with Alström develop dilated cardiomyopathy in infancy, and a second wave of cardiomyopathy emerges in adolescence and adulthood. Routine echocardiogram screening is part of Alström care and is not part of standard BBS care.⁴
Hearing loss
Sensorineural hearing loss appears in the first decade in around 70% of children with Alström and progresses through life. Hearing loss in BBS is less common and usually less severe.
Diabetes and insulin resistance
While both conditions feature insulin resistance, the severity in Alström is among the most extreme described in medicine. Type 2 diabetes appears earlier and is harder to control. Insulin requirements are often very high, and the typical metformin-based regimens used in BBS may be insufficient.⁵
Genitourinary
BBS commonly includes structural kidney malformations and hypogonadism that may be evident at birth or in early childhood. Alström features develop later — detrusor-urethral dyssynergia in late teens, hypogonadotropic hypogonadism around puberty, and slowly progressive nephropathy in adulthood.
Genetic testing as the tiebreaker
When clinical features overlap, genetic testing is decisive. A targeted ALMS1 test confirms or rules out Alström. A BBS panel covers all 22+ BBS genes. In ambiguous cases, a comprehensive ciliopathy panel covering both is ordered.⁶
A key difference for genetic counseling: Alström is caused by a single very large gene, while BBS is caused by many smaller genes. Recurrence risk to siblings is the same (25% with autosomal recessive inheritance) regardless, but carrier testing for relatives is simpler in Alström because only one gene is involved.
Why the difference matters for care
Surveillance
A child diagnosed with BBS does not get the same routine cardiac and audiology surveillance as a child with Alström. Misdiagnosis can delay catching cardiomyopathy or hearing loss in an Alström child.
Treatment
The severity of insulin resistance and the type of metabolic management differ. Alström may need more intensive diabetes care, potentially including very-high-dose insulin and adjunct medications.
Family planning
Both are autosomal recessive, but the genes involved and the carrier-screening strategies differ. A genetic counselor can help interpret the test results and plan for future pregnancies.
What if my child has features of both?
Some children initially clinically diagnosed with BBS — especially those without polydactyly and with severe cardiomyopathy — turn out to have Alström. The correct path is broader genetic testing. Ciliopathy panels often resolve these cases. We cover this in our misdiagnosis guide.
Common questions
Frequently asked questions
Short answers grounded in the article and the underlying references, so families can quickly understand the main point without losing the medical meaning.
Question
Can a person have both Alström and Bardet-Biedl Syndrome?
Answer
Inheriting both is theoretically possible but vanishingly rare given how rare each is. In practice, when features of both seem present, the explanation is almost always one condition with overlapping signs. Genetic testing resolves the ambiguity.
Question
Is Alström Syndrome more severe than Bardet-Biedl?
Answer
Alström generally involves more severe cardiac, audiologic, and metabolic features and a poorer prognosis on average, particularly because of cardiomyopathy. BBS more often involves intellectual disability and structural kidney malformations. "Worse" depends on which features matter most for a given individual.
Question
Why do both conditions cause obesity?
Answer
Both involve dysfunction of primary cilia in the hypothalamus, which regulates hunger and energy balance. The cilia-related signaling that tells the brain "you've eaten enough" is disrupted in both conditions, which contributes to weight gain that's hard to control by diet alone.
Question
Can the same gene panel test for both?
Answer
Yes — comprehensive ciliopathy panels cover ALMS1 and the BBS genes together. If your geneticist is unsure which condition is present, a single broader test is more efficient than two sequential tests.